What is Surmodics?
Surmodics operates at the intersection of advanced material science and clinical medicine. The company is recognized as a global leader in surface modification technologies, providing essential chemical components for in vitro diagnostic (IVD) immunoassay tests and microarrays. Beyond its chemical expertise, Surmodics designs and manufactures highly differentiated, complete medical devices aimed at addressing significant unmet clinical needs within the intravascular medicine space. Its market position is defined by a dual-track business model that balances high-margin component supply with the development of complex, finished medical products, ensuring a robust and diversified revenue stream.
How much funding has Surmodics raised?
Surmodics has raised a total of $140M across 2 funding rounds:
Stock Offering
$15M
Debt
$125M
Stock Issuance/Offering (1998): $15M, investors not publicly disclosed
Debt (2022): $125M led by MidCap Financial
Key Investors in Surmodics
MidCap Financial
MidCap Financial is a middle-market-focused finance firm that provides flexible, asset-based lending solutions to support the growth and operational requirements of healthcare and life sciences companies.
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Surmodics?
With the recent capital injection, Surmodics is well-positioned to accelerate its strategic roadmap, focusing on the expansion of its intravascular device portfolio and the refinement of its diagnostic chemical offerings. The company is expected to prioritize R&D initiatives that enhance the biocompatibility and performance of its surface modification platforms, thereby maintaining its competitive edge in a rapidly evolving healthcare landscape. As the firm transitions into its next phase of growth, management will likely focus on scaling production capabilities and deepening its penetration into high-growth clinical markets, ensuring that its technological innovations continue to meet the rigorous demands of modern medical practitioners and diagnostic laboratories worldwide.
See full Surmodics company page
